123 related articles for article (PubMed ID: 34957655)
41. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q
Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911
[TBL] [Abstract][Full Text] [Related]
42. HPV16 E6 gene polymorphisms and the functions of the mutation site in cervical cancer among Uygur ethnic and Han nationality women in Xinjiang, China.
Xin H; Pan Z; Zhe X; Zhang C; Li H; Zheng W; Long H; Shao R; Li D; Pan Z
Cancer Cell Int; 2022 Feb; 22(1):94. PubMed ID: 35193568
[TBL] [Abstract][Full Text] [Related]
43. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.
Subbaramaiah K; Dannenberg AJ
Cancer Res; 2007 Apr; 67(8):3976-85. PubMed ID: 17440114
[TBL] [Abstract][Full Text] [Related]
44. HPV E7 affects the function of cervical cancer cells via the TAL1/lnc‑EBIC/KLHDC7B axis.
Wang J; Xiang F; Liu X; Ma X; Cai X; Yang Y; Shen X; Yuan C; Xiang Y; Xiao H
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760214
[TBL] [Abstract][Full Text] [Related]
45. [Effects of hnRNP E1 on expression of early genes E2, E6 of HPV16 and biological function in cervical cancer cells].
Song L; Ding L; Feng MJ; Li XX; Gao W; Qi Z; Liu H; Wang M; Wang JT
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Feb; 42(2):321-326. PubMed ID: 33626623
[No Abstract] [Full Text] [Related]
46. Impact of modulation of telomerase and cancer stem-cell marker OCT4 axis in cervical cancer pathogenesis with underlying HPV16 infection.
Tiwari D; Ray Das C; Sultana R; Kakoti S; Aasif Khan M; Dongre A; Husain SA; Bose PD; Bose S
J Cell Biochem; 2020 Apr; 121(4):2782-2791. PubMed ID: 31692038
[TBL] [Abstract][Full Text] [Related]
47. Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer.
Han MS; Lee JM; Kim SN; Kim JH; Kim HS
Biomed Res Int; 2018; 2018():1942867. PubMed ID: 30627542
[TBL] [Abstract][Full Text] [Related]
48. [The role of human papillomavirus 16 early genes E2 and E6 and heterogeneous nuclear ribonucleoprotein E2 in cervical carcinogenesis and their interaction effect].
Gao W; Ding L; Song ZC; Feng MJ; Liu CL; Li XX; Song L; Lyu YJ; Wang JT
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jan; 54(1):92-98. PubMed ID: 31914575
[No Abstract] [Full Text] [Related]
49. Up-regulation of miR-20a by HPV16 E6 exerts growth-promoting effects by targeting PDCD6 in cervical carcinoma cells.
Liu X
Biomed Pharmacother; 2018 Jun; 102():996-1002. PubMed ID: 29710555
[TBL] [Abstract][Full Text] [Related]
50. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
[TBL] [Abstract][Full Text] [Related]
51. Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis.
Shukla S; Mahata S; Shishodia G; Pandey A; Tyagi A; Vishnoi K; Basir SF; Das BC; Bharti AC
PLoS One; 2013; 8(7):e67849. PubMed ID: 23874455
[TBL] [Abstract][Full Text] [Related]
52. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
53. Proinflammatory cytokine TNFα promotes HPV-associated oral carcinogenesis by increasing cancer stemness.
Hong HS; Akhavan J; Lee SH; Kim RH; Kang MK; Park NH; Shin KH
Int J Oral Sci; 2020 Jan; 12(1):3. PubMed ID: 31911577
[TBL] [Abstract][Full Text] [Related]
54. A novel intracellular nanobody against HPV16 E6 oncoprotein.
Zhang W; Shan H; Jiang K; Huang W; Li S
Clin Immunol; 2021 Apr; 225():108684. PubMed ID: 33549834
[TBL] [Abstract][Full Text] [Related]
55. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.
Li L; Xu C; Long J; Shen D; Zhou W; Zhou Q; Yang J; Jiang M
Oncotarget; 2015 Sep; 6(27):23930-43. PubMed ID: 26329329
[TBL] [Abstract][Full Text] [Related]
56. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
[TBL] [Abstract][Full Text] [Related]
57. Oncolytic Adenovirus H101 Synergizes with Radiation in Cervical Cancer Cells.
Duan Y; Bai H; Li X; Wang D; Wang Y; Cao M; Zhang N; Chen H; Wang Y
Curr Cancer Drug Targets; 2021; 21(7):619-630. PubMed ID: 33687882
[TBL] [Abstract][Full Text] [Related]
58. The miR-133b/brefeldin A-inhibited guanine nucleotide-exchange protein 1 (ARFGEF1) axis represses proliferation, invasion, and migration in cervical cancer cells.
Jiang L; Wang X
Bioengineered; 2022 Feb; 13(2):3323-3332. PubMed ID: 35048795
[TBL] [Abstract][Full Text] [Related]
59. HPV16 E6 oncoprotein-induced upregulation of lncRNA GABPB1-AS1 facilitates cervical cancer progression by regulating miR-519e-5p/Notch2 axis.
Ou R; Lv M; Liu X; Lv J; Zhao J; Zhao Y; Li X; Li W; Zhao L; Li J; Ren Y; Xu Y
FASEB J; 2020 Oct; 34(10):13211-13223. PubMed ID: 32844486
[TBL] [Abstract][Full Text] [Related]
60. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo.
Jung HS; Rajasekaran N; Song SY; Kim YD; Hong S; Choi HJ; Kim YS; Choi JS; Choi YL; Shin YK
Int J Mol Sci; 2015 May; 16(6):12243-60. PubMed ID: 26035754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
